Author:
Ott Gary,Barchfeld Gail L.,Chernoff David,Radhakrishnan Ramachandran,van Hoogevest Peter,Van Nest Gary
Reference38 articles.
1. Allison, A., and Byars, N., 1987, Vaccine technology: Adjuvants for increased efficacy, Biotechnology 5:1043–1045.
2. Allison, A. C., and Byars, N. E., 1990, Adjuvant formulations and their mode of action, Semin. Immunol. 2:369–374.
3. Audibert, F. M., Parant, C., Damais, C., Lefrancier, P., Denien, M., Choay, J., and Chedid, L., 1980, Disassociation of immunostimulating activities of muramyldipeptide (MDP) by linking of amino acids or peptides to the glutaminyl residue, Biochem. Biophys. Res. Commun. 96:915–923.
4. Boyd, J., Parkinson, C., and Sherman, P., 1972, Factors affecting emulsion stability and the HLB concept, J. Colloid Interfac. Sci. 41:359–370.
5. Brynestad, K., Babbit, B., Huang, L., and Rouse, B. T., 1990, Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1–23 peptide of glycoprotein D of herpes simplex virus: Implications for subunit vaccines, J. Virol. 64:680–685.
Cited by
195 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献